Chunhua Yang

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Topics

Ulcerative Colitis

Acinetobacter Baumannii

Top Venues

Inflammatory bowel diseases

Nanomaterials (Basel, Switzerland)

Expert opinion on drug delivery

This page only lists publications with an associated author ORCID identifier.

Publications

Chunhua Yang, Didier Merlin
Unveiling Colitis: A Journey through the Dextran Sodium Sulfate-induced Model. Inflammatory bowel diseases 30 (5) (2024)
Chunhua Yang, Didier Merlin
Unveiling Colitis: A Journey through the Dextran Sodium Sulfate-induced Model. Inflammatory bowel diseases 30 (5) (2024)
Chunhua Yang, Didier Merlin
Unveiling Colitis: A Journey through the Dextran Sodium Sulfate-induced Model. Inflammatory bowel diseases 30 (5) (2024)
Chunhua Yang, Didier Merlin
Unveiling Colitis: A Journey through the Dextran Sodium Sulfate-induced Model. Inflammatory bowel diseases (2024)
Chunhua Yang, Didier Merlin
Unveiling Colitis: A Journey through the Dextran Sodium Sulfate-induced Model. Inflammatory bowel diseases 30 (5) (2024)
Dingpei Long, Zahra Alghoul, Junsik Sung, Chunhua Yang, Didier Merlin
Prevention of Colitis-Associated Cancer via Oral Administration of M13-Loaded Lipid Nanoparticles. Pharmaceutics 15 (9) (2023)
Dingpei Long, Zahra Alghoul, Junsik Sung, Chunhua Yang, Didier Merlin
Oral administration of M13-loaded nanoliposomes is safe and effective to treat colitis-associated cancer in mice. Expert opinion on drug delivery (2023)
Dingpei Long, Zahra Alghoul, Junsik Sung, Chunhua Yang, Didier Merlin
Oral administration of M13-loaded nanoliposomes is safe and effective to treat colitis-associated cancer in mice. Expert opinion on drug delivery (2023)
Chunhua Yang, Didier Merlin
Challenges to Safe Nanomedicine Treatment. Nanomaterials (Basel, Switzerland) 13 (7) (2023)
Mei Yang, Chunhua Yang, Yujie Zhang, Xiangji Yan, Yana Ma, Yuanyuan Zhang, Yameng Cao, Qiuran Xu, Kangsheng Tu, Mingzhen Zhang
An oral pH-activated "nano-bomb" carrier combined with berberine by regulating gene silencing and gut microbiota for site-specific treatment of ulcerative colitis. Biomaterials science 10 (4) (2022)
Zahra Alghoul, Chunhua Yang, Didier Merlin
The Current Status of Molecular Biomarkers for Inflammatory Bowel Disease. Biomedicines 10 (7) (2022)
Chunhua Yang, Junsik Sung, Dingpei Long, Zahra Alghoul, Didier Merlin
Prevention of Ulcerative Colitis by Autologous Metabolite Transfer from Colitogenic Microbiota Treated with Lipid Nanoparticles Encapsulating an Anti-Inflammatory Drug Candidate. Pharmaceutics 14 (6) (2022)
Chunhua Yang, Gianfranco Alpini, Shannon Glaser, Didier Merlin
Lipid nanoparticles for oral delivery of nucleic acids for treating inflammatory bowel disease. Nanomedicine (London, England) (2022)
Junsik Sung, Lixin Wang, Dingpei Long, Chunhua Yang, Didier Merlin
PepT1-knockout mice harbor a protective metabolome beneficial for intestinal wound healing. American journal of physiology. Gastrointestinal and liver physiology 320 (5) (2021)
Chunhua Yang, Dingpei Long, Junsik Sung, Zahra Alghoul, Didier Merlin
Orally Administered Natural Lipid Nanoparticle-Loaded 6-Shogaol Shapes the Anti-Inflammatory Microbiota and Metabolome. Pharmaceutics 13 (9) (2021)
Chunhua Yang, Didier Merlin
Lipid-Based Drug Delivery Nanoplatforms for Colorectal Cancer Therapy. Nanomaterials (Basel, Switzerland) 10 (7) (2020)
Chunhua Yang, Didier Merlin
Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives. International journal of nanomedicine 14 (2019)